Blueprint for the development of plant-derived vaccines for the poor in developing countries

dc.contributor.authorPROVACSen
dc.contributor.departmentSustainable Agriculture and Natural Resource Management (SANREM) Knowledgebaseen
dc.date.accessioned2016-04-19T18:55:35Zen
dc.date.available2016-04-19T18:55:35Zen
dc.date.issued2005en
dc.descriptionMetadata only recorden
dc.description.abstractThis Blueprint is the result of a series of international consultations and demonstrates that the development of plant-derived vaccines is both straightforward and achievable. A particular benefit of plant-derived vaccines is that their production could easily and economically be established in developing countries. The production in plants of large quantities of vaccines for oral administration is poised to revolutionize the world of vaccination and help bring to the poor the promise of existing and new vaccines for controlling infectious diseases. Due to economic and market realities, this promise will be achieved only through the collaboration of the public and private sectors with significant investments by both parties. These investments, however, will yield rich dividends in the form of widely available, inexpensive, orally administered, heat stable vaccines. The document specifically discusses pathways to produce vaccines against hepatitis B virus (HBV) and human papilloma virus (HPV) but also apply to other pathogens.en
dc.description.notesavailable in SANREM-CRSP office, ESen
dc.format.mimetypetext/plainen
dc.identifier1025en
dc.identifier.citationPrepared by PROVACS-Production of Vaccines from Applied Crop Sciences, A Program of The Center for Infectious Diseases and Vaccinology, The BioDesign Institute at Arizona State University, Tempe, Arizonaen
dc.identifier.urihttp://hdl.handle.net/10919/65903en
dc.language.isoen_USen
dc.rightsIn Copyrighten
dc.rights.holderCopyright 2005. Center for Infectious Diseases and Vaccinology, Biodesign Institute, Arizona State University. All Rights Reserved.en
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.subjectPlantsen
dc.subjectMedical servicesen
dc.subjectDisease controlen
dc.subjectPovertyen
dc.subjectHealth impactsen
dc.subjectHealthen
dc.subjectPlant-derived vaccinesen
dc.subjectInfectious diseaseen
dc.subjectHepatitis b virus (hbv)en
dc.subjectHuman papilloma virus (hpv)en
dc.subjectGovernanceen
dc.titleBlueprint for the development of plant-derived vaccines for the poor in developing countriesen
dc.typeAbstracten
dc.type.dcmitypeTexten

Files